NCT00605111 - Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

193

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Trial Locations (17)

500

Novo Nordisk Investigational Site, Changhua

807

Novo Nordisk Investigational Site, Kaoshiung

1100

Novo Nordisk Investigational Site, Quezon City

2148

Novo Nordisk Investigational Site, Blacktown

2292

Novo Nordisk Investigational Site, Broadmeadow

2605

Novo Nordisk Investigational Site, Garran

3065

Novo Nordisk Investigational Site, Fitzroy

4120

Novo Nordisk Investigational Site, Stones Corner

6000

Novo Nordisk Investigational Site, Cebu City

10300

Novo Nordisk Investigational Site, Bangkok

10330

Novo Nordisk Investigational Site, Bangkok

10450

Novo Nordisk Investigational Site, Georgetown, Penang

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

56000

Novo Nordisk Investigational Site, Cheras

159964

Novo Nordisk Investigational Site, Singapore

Unknown

Novo Nordisk Investigational Site, Hong Kong Island

Novo Nordisk Investigational Site, Shatin, New Territories